newsfilter
← Latest News
GlobeNewswire·

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

REYKJAVIK, Iceland, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO, ALVO-SDB)) (the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines